Belinda S. Cowling is a French medical researcher and cofounder and scientific advisor of the biotech firm Dynacure, which was founded in 2016. She became Head of Research in 2018, responsible for the company’s R&D strategy, and leading Dynacure’s research programs in centronuclear myopathy (CNM) and other disease domains. As Dynacure's Chief Scientific Officer, her focus is on translational research and drug-candidate development. In 2019, she was awarded the Irène Joliot-Curie Prize in the category: Women, Research and Enterprise.
Attributes | Values |
---|---|
rdf:type | |
rdfs:label |
|
rdfs:comment |
|
foaf:name |
|
name |
|
dct:subject | |
Wikipage page ID |
|
Wikipage revision ID |
|
Link from a Wikipage to another Wikipage |
|
sameAs | |
dbp:wikiPageUsesTemplate | |
alma mater | |
known for |
|
nationality |
|
occupation |
|
has abstract |
|
prov:wasDerivedFrom | |
page length (characters) of wiki page |
|
alma mater | |
occupation | |
foaf:isPrimaryTopicOf | |
is Link from a Wikipage to another Wikipage of | |
is Wikipage disambiguates of | |
is foaf:primaryTopic of |